Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxim Totrov

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|October 6, 2023
<i>In vitro</i> potency of xeruborbactam in combination with multiple β-lactam antibiotics in comparison with other β-lactam/β-lactamase inhibitor (BLI) combinations against carbapenem-resistant and extended-spectrum β-lactamase-producing <i>Enterobacterales</i>Olga Lomovskaya, Mariana Castanheira, Jill Lindley, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2003
Discovery of diverse thyroid hormone receptor antagonists by high-throughput dockingMatthieu Schapira, Bruce M Raaka, Sharmistha Das, et al.
Chemico-Biological Interactions|September 20, 2012
Aryl methylcarbamates: potency and selectivity towards wild-type and carbamate-insensitive (G119S) Anopheles gambiae acetylcholinesterase, and toxicity to G3 strain An. gambiaeDawn M Wong, Jianyong Li, Polo C H Lam, et al.
Journal of Virology|July 29, 2011
Cross-clade HIV-1 neutralizing antibodies induced with V3-scaffold protein immunogens following priming with gp120 DNASusan Zolla-Pazner, X-P Kong, Xunqing Jiang, et al.
Structure (London, England : 1993)|May 14, 2011
Structural analysis of human and macaque mAbs 2909 and 2.5B: implications for the configuration of the quaternary neutralizing epitope of HIV-1 gp120Brett Spurrier, Jared M Sampson, Maxim Totrov, et al.
Vaccine|April 23, 2016
Induction of neutralizing antibodies in rhesus macaques using V3 mimotope peptidesAnn J Hessell, Sean McBurney, Shilpi Pandey, et al.
Proteins|June 3, 2015
Structural genomics for drug design against the pathogen Coxiella burnetiiMatthew C Franklin, Jonah Cheung, Michael J Rudolph, et al.
ACS Infectious Diseases|January 14, 2025
Stereospecific Resistance to N2-Acyl Tetrahydro-β-carboline Antimalarials Is Mediated by a PfMDR1 Mutation That Confers Collateral Drug SensitivityEmily K Bremers, Joshua H Butler, Leticia S Do Amaral, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Enantiopure Benzofuran-2-carboxamides of 1-Aryltetrahydro-β-carbolines Are Potent Antimalarials <i>In Vitro</i>Hanan Almolhim, Sha Ding, Joshua H Butler, et al.
Scientific Reports|January 12, 2018
Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine TrialsPreetha Balasubramanian, Constance Williams, Mariya B Shapiro, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|October 6, 2023
<i>In vitro</i> potency of xeruborbactam in combination with multiple β-lactam antibiotics in comparison with other β-lactam/β-lactamase inhibitor (BLI) combinations against carbapenem-resistant and extended-spectrum β-lactamase-producing <i>Enterobacterales</i>Olga Lomovskaya, Mariana Castanheira, Jill Lindley, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2003
Discovery of diverse thyroid hormone receptor antagonists by high-throughput dockingMatthieu Schapira, Bruce M Raaka, Sharmistha Das, et al.
Chemico-Biological Interactions|September 20, 2012
Aryl methylcarbamates: potency and selectivity towards wild-type and carbamate-insensitive (G119S) Anopheles gambiae acetylcholinesterase, and toxicity to G3 strain An. gambiaeDawn M Wong, Jianyong Li, Polo C H Lam, et al.
Journal of Virology|July 29, 2011
Cross-clade HIV-1 neutralizing antibodies induced with V3-scaffold protein immunogens following priming with gp120 DNASusan Zolla-Pazner, X-P Kong, Xunqing Jiang, et al.
Structure (London, England : 1993)|May 14, 2011
Structural analysis of human and macaque mAbs 2909 and 2.5B: implications for the configuration of the quaternary neutralizing epitope of HIV-1 gp120Brett Spurrier, Jared M Sampson, Maxim Totrov, et al.
Vaccine|April 23, 2016
Induction of neutralizing antibodies in rhesus macaques using V3 mimotope peptidesAnn J Hessell, Sean McBurney, Shilpi Pandey, et al.
Proteins|June 3, 2015
Structural genomics for drug design against the pathogen Coxiella burnetiiMatthew C Franklin, Jonah Cheung, Michael J Rudolph, et al.
ACS Infectious Diseases|January 14, 2025
Stereospecific Resistance to N2-Acyl Tetrahydro-β-carboline Antimalarials Is Mediated by a PfMDR1 Mutation That Confers Collateral Drug SensitivityEmily K Bremers, Joshua H Butler, Leticia S Do Amaral, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Enantiopure Benzofuran-2-carboxamides of 1-Aryltetrahydro-β-carbolines Are Potent Antimalarials <i>In Vitro</i>Hanan Almolhim, Sha Ding, Joshua H Butler, et al.
Scientific Reports|January 12, 2018
Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine TrialsPreetha Balasubramanian, Constance Williams, Mariya B Shapiro, et al.
Pageof 8